High ambient glucose levels modulates the production of MMP-9 and α5(IV) collagen by cultured podocytes

被引:58
作者
Bai, YL [1 ]
Wang, LZ [1 ]
Li, YQ [1 ]
Liu, SY [1 ]
Li, JZ [1 ]
Wang, HY [1 ]
Huang, HC [1 ]
机构
[1] Peking Univ, Hosp 1, Div Nephrol, Beijing 100034, Peoples R China
关键词
diabetic nephropathy; glomerular epithelial cells; glomerulosclerosis; extracellular matrix; glomerular filtration barrier;
D O I
10.1159/000091464
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Recent evidences have demonstrated an important role for glomerular visceral epithelial cell ( podocyte) in the development and progression of diabetic nephropathy. We investigated the high-glucose (HG)-triggered signaling pathway and its role in matrix metalloproteinase (MMP) production in murine podocytes. The activity of 92-kDa (MMP-9) gelatinase, but not of 72 kDa (MMP-2), in an HG medium significantly increased during incubation of 2 to 3 days and decreased during incubation of more than 5 days revealed by Gelatin zymography. Opposite to the increases in MMP-9 activity, HG medium produced significant decreases in the protein levels of alpha 5(IV) collagen. Changes in MMP-9 activity were associated with the same pattern as MMP-9 mRNA levels in podocytes exposed to HG media. HG medium rapidly activated ERK1/2 MAPK in podocytes. Moreover, ERK1/2 activation was required for HG-induced enhancement of MMP-9 activity and a decrease in the level of a5( IV) collagen. HG incubation rapidly induced an increase in the nuclear accumulation of Ets-1 protein. Blocking the ERK pathway suppressed HG-induced expression and nuclear accumulation of transcriptional factor Ets-1, and MMP-9 mRNA expression. We suggest that short-or long-term exposure to HG concentrations increases or decreases MMP-9 production and alpha 5(IV) collagen expression in podocytes, this may contribute to the GBM abnormality caused by an imbalance in extracellular matrix (ECM) synthesis and degradation, and may play a critical role in the pathogenesis of proteinuria in diabetic nephropathy. Copyright (c) 2006 S. Karger AG, Basel.
引用
收藏
页码:57 / 68
页数:12
相关论文
共 42 条
[11]   Mitogen-activated protein kinase cascade is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions [J].
Haneda, M ;
Araki, S ;
Togawa, M ;
Sugimoto, T ;
Isono, M ;
Kikkawa, R .
DIABETES, 1997, 46 (05) :847-853
[12]   Podocyte injury promotes progressive nephropathy in Zucker diabetic fatty rats [J].
Hoshi, S ;
Shu, YJ ;
Yoshida, F ;
Inagaki, T ;
Sonoda, J ;
Watanabe, T ;
Nomoto, K ;
Nagata, M .
LABORATORY INVESTIGATION, 2002, 82 (01) :25-35
[13]   Glucose or diabetes activates p38 mitogen-activated protein kinase via different pathways [J].
Igarashi, M ;
Wakasaki, H ;
Takahara, N ;
Ishii, H ;
Jiang, ZY ;
Yamauchi, T ;
Kuboki, K ;
Meier, M ;
Rhodes, CJ ;
King, GL .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (02) :185-195
[14]   Prostaglandin E2 enhances pancreatic cancer invasiveness through an Ets-1-dependent induction of matrix metalloproteinase-2 [J].
Ito, H ;
Duxbury, M ;
Benoit, E ;
Clancy, TE ;
Zinner, MJ ;
Ashley, SW ;
Whang, EE .
CANCER RESEARCH, 2004, 64 (20) :7439-7446
[15]   Progression of diabetic nephropathy [J].
Kikkawa, R ;
Koya, D ;
Haneda, M .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) :S19-S21
[16]   METALLOPROTEINASE GENERATION BY HUMAN GLOMERULAR EPITHELIAL-CELLS [J].
KNOWLDEN, J ;
MARTIN, J ;
DAVIES, M ;
WILLIAMS, JD .
KIDNEY INTERNATIONAL, 1995, 47 (06) :1682-1689
[17]  
Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574
[18]   ERK-dependent signaling pathway and transcriptional factor Ets-1 regulate matrix metalloproteinase-9 production in transforming growth factor-β1 stimulated glomerular podocytes [J].
Liu, SY ;
Liang, Y ;
Huang, HC ;
Wang, LZ ;
Li, YQ ;
Li, JZ ;
Li, XM ;
Wang, HY .
CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2005, 16 (4-6) :207-216
[19]   NEUTRAL PROTEINASE ACTIVITY PRODUCED INVITRO BY CELLS OF THE GLOMERULAR MESANGIUM [J].
LOVETT, DH ;
STERZEL, RB ;
KASHGARIAN, M ;
RYAN, JL .
KIDNEY INTERNATIONAL, 1983, 23 (02) :342-349
[20]  
Martin J, 1998, J AM SOC NEPHROL, V9, P1629